- United States
- /
- Insurance
- /
- NasdaqGS:AIFU
It's Down 27% But Fanhua Inc. (NASDAQ:FANH) Could Be Riskier Than It Looks
The Fanhua Inc. (NASDAQ:FANH) share price has fared very poorly over the last month, falling by a substantial 27%. The drop over the last 30 days has capped off a tough year for shareholders, with the share price down 39% in that time.
Even after such a large drop in price, there still wouldn't be many who think Fanhua's price-to-sales (or "P/S") ratio of 0.6x is worth a mention when the median P/S in the United States' Insurance industry is similar at about 1.1x. Although, it's not wise to simply ignore the P/S without explanation as investors may be disregarding a distinct opportunity or a costly mistake.
Check out our latest analysis for Fanhua
How Has Fanhua Performed Recently?
Fanhua's revenue growth of late has been pretty similar to most other companies. Perhaps the market is expecting future revenue performance to show no drastic signs of changing, justifying the P/S being at current levels. If this is the case, then at least existing shareholders won't be losing sleep over the current share price.
Keen to find out how analysts think Fanhua's future stacks up against the industry? In that case, our free report is a great place to start.Do Revenue Forecasts Match The P/S Ratio?
In order to justify its P/S ratio, Fanhua would need to produce growth that's similar to the industry.
Taking a look back first, we see that the company grew revenue by an impressive 19% last year. Still, revenue has fallen 1.9% in total from three years ago, which is quite disappointing. So unfortunately, we have to acknowledge that the company has not done a great job of growing revenues over that time.
Looking ahead now, revenue is anticipated to climb by 19% during the coming year according to the lone analyst following the company. Meanwhile, the rest of the industry is forecast to only expand by 6.4%, which is noticeably less attractive.
With this information, we find it interesting that Fanhua is trading at a fairly similar P/S compared to the industry. Apparently some shareholders are skeptical of the forecasts and have been accepting lower selling prices.
The Final Word
Fanhua's plummeting stock price has brought its P/S back to a similar region as the rest of the industry. Generally, our preference is to limit the use of the price-to-sales ratio to establishing what the market thinks about the overall health of a company.
Despite enticing revenue growth figures that outpace the industry, Fanhua's P/S isn't quite what we'd expect. When we see a strong revenue outlook, with growth outpacing the industry, we can only assume potential uncertainty around these figures are what might be placing slight pressure on the P/S ratio. At least the risk of a price drop looks to be subdued, but investors seem to think future revenue could see some volatility.
There are also other vital risk factors to consider and we've discovered 4 warning signs for Fanhua (2 can't be ignored!) that you should be aware of before investing here.
If these risks are making you reconsider your opinion on Fanhua, explore our interactive list of high quality stocks to get an idea of what else is out there.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NasdaqGS:AIFU
AIX
Together with its subsidiary, distributes insurance products in China.
Excellent balance sheet and good value.